Journal profile · Allergy
Clinical Reviews in Allergy & Immunology
ISSN 1080-0549 · eISSN 1559-0267 · Springer US · UNITED STATES · Bimonthly · Founded 1983
Clinical Reviews in Allergy & Immunology: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 9.05; hybrid open access; APC about USD 5,490; median 66 days to acceptance (61 articles, last 24 months); community-reported acceptance: moderate; 110 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical Reviews in Allergy & Immunology is published by Springer US and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Systemic Lupus Erythematosus Research and Allergic Rhinitis and Sensitization, together about 29.1% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
This journal publishes scholarly reviews and experimental papers that address the state of the art in the management of allergic and immunologic diseases and in particular place newly available data into perspective. Each issue of the journal is devoted to a single theme of critical importance to allergists and immunologists, with the goal of providing a comprehensive treatment of the subject that will benefit a wide readership. Readers will find the journal of value in elucidating the impact of novel data on clinical management against the background of advances such as the development of standardized protocols for allergy skin testing and challenge procedures and improved understanding of cell biology. The ultimate objective is to help improve the care and management of patients with immune-mediated disease.
From the journal's Aims & Scope
Research area (LetPub): Allergy
Editor-in-chief Christopher ChangPublisher website
Editorial board by country: 5 in mainland China (about 15%); most named United States 15, Mainland China 5, United Kingdom 3, France 2, Hong Kong, China 1 (33 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine11.2%
- Systemic Lupus Erythematosus ResearchMedicine9.3%
- Allergic Rhinitis and SensitizationMedicine8.6%
- Food Allergy and Anaphylaxis ResearchMedicine6.8%
- Dermatology and Skin DiseasesMedicine4.7%
- T-cell and B-cell ImmunologyImmunology and Microbiology4.7%
- Urticaria and Related ConditionsMedicine4.5%
- Immune Cell Function and InteractionImmunology and Microbiology3.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Allergy | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 9.05LetPub ·
- Impact factor (publisher) 2025
- 11.5Publisher website ·
- 5-year impact factor (publisher) 2025
- 12.7Publisher website ·
- CiteScore 2026-06
- 20.2LetPub ·
- SJR 2026-06
- 3.29LetPub ·
- SNIP 2026-06
- 3.78LetPub ·
- h-index
- 67LetPub ·
- h-index
- 135OpenAlex ·
- i10-index
- 1,299OpenAlex ·
- 2-year mean citedness
- 9.2OpenAlex ·
- Self-citation rate
- 2.6%LetPub ·
- Share of gold OA articles
- 32.12%LetPub ·
Volume
- Articles per year
- 109LetPub ·
- Downloads per year (publisher) 2025
- 841,200Publisher website ·
Articles by year OpenAlex count · 1,753 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 80 | 31 | 56 |
| 2025 | 110 | 38 | 1,120 |
| 2024 | 38 | 12 | 921 |
| 2023 | 18 | 7 | 438 |
| 2022 | 50 | 25 | 3,128 |
| 2021 | 82 | 40 | 5,239 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
66 daysMedian, submission to acceptance · P25–P75 53 days – 93 days
- Acceptance to online
- median 19 days (104 articles)
- Submission to online
- median 94 days
- Sample
- 61 articles with submission and acceptance dates (198 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 8 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 5,490 / EUR 4,190 / GBP 3,590 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
Other charges and waivers (author guidelines)
- Page charges
- No page charges
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare5 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
- Templates
- LaTeX and Word
- Suggested reviewers
- Optional
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Clinical Reviews in Allergy & Immunology, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1983
- ISSN
- 1080-0549
- Electronic ISSN
- 1559-0267
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical Reviews in Allergy & Immunology
What CAS zone is Clinical Reviews in Allergy & Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical Reviews in Allergy & Immunology is in Zone 1 of Medicine, and in Zone 1 of the minor category Allergy / Immunology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical Reviews in Allergy & Immunology?
The latest impact factor listed by LetPub is 9.05; CiteScore 20.2, h-index 135.
How long does peer review take at Clinical Reviews in Allergy & Immunology?
Based on the dates recorded on 61 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 66 days (interquartile range 53–93 days); authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Clinical Reviews in Allergy & Immunology?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation; Templates: LaTeX and Word; Suggested reviewers: Optional. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Clinical Reviews in Allergy & Immunology based?
Of the 33 board members whose country the journal's board page names, 5 (about 15%) are in mainland China; the countries named most often are United States (15), Mainland China (5) and United Kingdom (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical Reviews in Allergy & Immunology?
According to LetPub and DOAJ records, Clinical Reviews in Allergy & Immunology is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Clinical Reviews in Allergy & Immunology open access, and what is the APC?
Clinical Reviews in Allergy & Immunology is a hybrid journal. For open-access publication: APC about USD 5,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .